Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe site revision label was updated from v3.6.4 to v3.6.5, indicating a software update to the platform. No study content or user-facing information appears to have changed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a new version of the page and its metadata.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a new site build; no study content or critical information appears to be altered.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision indicator has been updated from v3.6.0 to v3.6.2. This reflects a metadata update rather than any substantive changes to trial information or content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now includes new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and shows 'No longer looking for participants' in recruitment. The 'Intervention / Treatment' header has been changed to 'Intervention/Treatment', and the footer revision updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check76 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new build of the page. This change does not alter the study details or any visible content.SummaryDifference0.1%

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.